Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The molecular size of the antithrombin-binding sequence in heparin.

Literature DB >> 7409165

The molecular size of the antithrombin-binding sequence in heparin.

L Thunberg, G Bäckström, H Grundberg, J Riesenfeld, U Lindahl.

Abstract

Entities: Chemical Gene

Mesh：

Substances：

Year: 1980 PMID： 7409165 DOI： 10.1016/0014-5793(80)80945-8

Source DB: PubMed Journal: FEBS Lett ISSN： 0014-5793 Impact factor: 4.124

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Nitric oxide degradation of heparin and heparan sulphate.

Authors: R E Vilar; D Ghael; M Li; D D Bhagat; L M Arrigo; M K Cowman; H S Dweck; L Rosenfeld
Journal: Biochem J Date: 1997-06-01 Impact factor: 3.857

2. Binding of heparin to human platelet factor 4.

Authors: S W Cowan; E N Bakshi; K J Machin; N W Isaacs
Journal: Biochem J Date: 1986-03-01 Impact factor: 3.857

Review 3. Mechanism of the anticoagulant action of heparin.

Authors: I Björk; U Lindahl
Journal: Mol Cell Biochem Date: 1982-10-29 Impact factor: 3.396

4. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.

Authors: D A Lane; J Denton; A M Flynn; L Thunberg; U Lindahl
Journal: Biochem J Date: 1984-03-15 Impact factor: 3.857

5. Binding of platelet factor 4 to heparin oligosaccharides.

Authors: J Denton; D A Lane; L Thunberg; A M Slater; U Lindahl
Journal: Biochem J Date: 1983-02-01 Impact factor: 3.857

6. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies.

Authors: B Casu; P Oreste; G Torri; G Zoppetti; J Choay; J C Lormeau; M Petitou; P Sinäy
Journal: Biochem J Date: 1981-09-01 Impact factor: 3.857

The molecular size of the antithrombin-binding sequence in heparin.

1. Nitric oxide degradation of heparin and heparan sulphate.

2. Binding of heparin to human platelet factor 4.

Review 3. Mechanism of the anticoagulant action of heparin.

4. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.

5. Binding of platelet factor 4 to heparin oligosaccharides.

6. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies.

7. Multiple functional domains of the heparin molecule.

8. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.

9. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.

10. Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.